NOTICE OF UPGRADE
Our websites will be unavailable between the hours of AEST 4AM September 17, 2022 and AEST 11PM on date September 18, 2022
SEARCH LISTED COMPANY
Any AUS or NZ company
SEARCH PRIVATE COMPANY
SEARCH FUNDS
Find any Australian or New Zealand company or fund (dead or alive) by using SEARCH above or go directly to the site:
|
|
09 September 2024
| Name: | ELLEX MEDICAL LASERS LIMITED (ELX) (This company subsequently changed its name to NOVA EYE MEDICAL LIMITED. You should refer to that name for Status.) | ||||||
| ISIN: | AU000000ELX4 | ||||||
| Date of Listing: | 12 October 1987 | ||||||
| Subsequent Names: |
| ||||||
| Former Names: |
|
Stock Exchange Status: (updated daily)
This company subsequently changed its name to NOVA EYE MEDICAL LIMITED. You should refer to that name for Stock Exchange Status.Legal Status: (updated monthly)
This company subsequently changed its name to NOVA EYE MEDICAL LIMITED. You should refer to that name for Legal Status.Capital Gains Tax (CGT) Status: (updated at least quarterly)
This company subsequently changed its name and is now NOVA EYE MEDICAL LIMITED. You should refer to that name for Capital Gains Tax Status.
Updates, corrections, disagreements please email to admin@delisted.com.au
Further information: deListed and InvestoGain are operated by Investogain Pty Limited which is licensed by ASIC as an Australian Financial Services Licensee (AFSL 334036). deListed acquires only securities that it deems to be of little or no value, in circumstances where the holder is unable to sell their securities on-market in the normal manner. This service has been provided online via the company’s website www.delisted.com.au since 2004.
Getting advice: Information provided in this section is of a general nature and applicable only to Australian tax residents who hold their investments on capital account (ie for long-term investment purposes). It has been prepared without taking into account your financial needs or tax situation. Before acting on the information, deListed suggests that you consider whether it is appropriate for your circumstances and recommends that you seek independent legal, financial, or taxation advice.
Disclaimer: The information provided above is to the best of our knowledge accurate as of today. But you should bear in mind that it is of a general nature and does not constitute financial or tax advice. Investogain Pty Limited accepts no liability for any loss arising from reliance on this information, including reliance on information that is no longer current.
| FROM | TO | |
| NOVA EYE MEDICAL LIMITED | 03/07/2020 | |
| ELLEX MEDICAL LASERS LIMITED | 31/07/2001 | 03/07/2020 |
| GEMSTONE CORPORATION OF AUSTRALIA LIMITED | 31/07/2001 |
Computershare Adelaide
Level 5, 115 Grenfell Street, Adelaide SA 5000
Tel : +61 (0)3 9415 4000 or 1300 850 505 (within Australia)
Fax : +61 8 9473 2408 or 1300 534 987
RegistryWebsite RegistryEmail
Expand this box to read and print
name changed to Nova Eye Medical Limited | 03/07/2020 |
The suspension of trading in the securities of Ellex Medical Lasers Limited will be lifted immediately, following the release by ELX of an announcement regarding an agreement for the sale of the Ellex Lasers & Ultrasound business. | 24/12/2019 |
A$100 million in cash, representing 1.5x Lasers & Ultrasound FY19 revenues1 and 10.6x FY19 EBITDA. Net cash proceeds of approximately $97 million, after adjustments for Ellex iTrack, 2RT and allocated corporate expenditure prior to the completion date. Ellex shareholders to vote on the proposed sale, with transaction close expected by late March 2020. Ellex Board of Directors unanimously recommend the transaction. Ellex Board committed to returning majority of net funds received to shareholders. Post transaction, Ellex will be debt-free and will be primarily focused on devices to treat glaucoma in a growing, underpenetrated global market and 2RT for macular degeneration. | 24/12/2019 |
The suspension is requested until the commencement of trading on Wednesday 15 January 2020 or such earlier time as Ellex makes an announcement to the market in respect of the proposed transaction. | 12/12/2019 |
The company releases the results of its meeting. | 28/11/2019 |
The company releases 2019 AGM Presentation. | 28/11/2019 |
The company releases its CEO address. | 28/11/2019 |
The company releases the Chairman's Address to Shareholders. | 28/11/2019 |
The securities of Ellex Medical Lasers Limited will be suspended from quotation immediately under Listing Rule 17.2, at the request of ELX, pending the release of an announcement regarding a proposed sale of a key business segment. | 28/11/2019 |
name changed from Gemstone Corporation of Australia Limited | 31/07/2001 |
name changed to Nova Eye Medical Limited | 03/07/2020 |
The suspension of trading in the securities of Ellex Medical Lasers Limited will be lifted immediately, following the release by ELX of an announcement regarding an agreement for the sale of the Ellex Lasers & Ultrasound business. | 24/12/2019 |
A$100 million in cash, representing 1.5x Lasers & Ultrasound FY19 revenues1 and 10.6x FY19 EBITDA. Net cash proceeds of approximately $97 million, after adjustments for Ellex iTrack, 2RT and allocated corporate expenditure prior to the completion date. Ellex shareholders to vote on the proposed sale, with transaction close expected by late March 2020. Ellex Board of Directors unanimously recommend the transaction. Ellex Board committed to returning majority of net funds received to shareholders. Post transaction, Ellex will be debt-free and will be primarily focused on devices to treat glaucoma in a growing, underpenetrated global market and 2RT for macular degeneration. | 24/12/2019 |
The suspension is requested until the commencement of trading on Wednesday 15 January 2020 or such earlier time as Ellex makes an announcement to the market in respect of the proposed transaction. | 12/12/2019 |
The company releases the results of its meeting. | 28/11/2019 |
The company releases 2019 AGM Presentation. | 28/11/2019 |
The company releases its CEO address. | 28/11/2019 |
The company releases the Chairman's Address to Shareholders. | 28/11/2019 |
The securities of Ellex Medical Lasers Limited will be suspended from quotation immediately under Listing Rule 17.2, at the request of ELX, pending the release of an announcement regarding a proposed sale of a key business segment. | 28/11/2019 |
name changed from Gemstone Corporation of Australia Limited | 31/07/2001 |
Your browser may reflect a date of printing in American format.
Purchases Sales
| DATE | DIRECTOR | NUMBER | PRICE | AMOUNT |
|---|---|---|---|---|
| 26/10/2019 | Mike Southard | 20,000 | $0.746 | $14,910 |
| 28/05/2018 | Rahmon Coupe | 26,251 | $0.590 | $15,488 |
| 07/05/2018 | Rahmon Coupe | 13,749 | $0.740 | $10,174 |
| 10/10/2016 | Rahmon Coupe | -60,000 | $1.227 | $73,600 |
| 04/10/2016 | Rahmon Coupe | -54,600 | $1.195 | $65,246 |
| NAME | TITLE | DATE OF APPT |
|---|---|---|
| Victor Previn | Executive Chairman | 16/07/2001 |
| Rahmon Coupe | Independent Director | 17/05/2013 |
| Alexander Sundich | Non Exec Director | 25/07/2005 |
| Mike Mangano | Director | 02/07/2018 |
| Mike Southard | Director | 02/07/2018 |
| Simon Gray | Company Secretary |
Date of first appointment, title may have changed.
| NAME | TITLE | DATE OF APPOINTMENT | DATE OF RESIGNATION |
|---|---|---|---|
| Maria Maieli | CEO | 19/07/2019 | 18/02/2020 |
| Giuseppe Canala | Non Exec Director | 17/10/2008 | 27/11/2019 |
| Gerard Wallace | CEO | 08/04/2019 | 19/07/2019 |
| Tom Spurling | CEO | 31/03/2011 | 05/04/2019 |
| Meera Verma | Independent Director | 17/05/2013 | 15/05/2018 |
| Malcolm Plunkett | Executive Director | 17/10/2008 | 04/04/2013 |
Date of first appointment, title may have changed.
Contact Us | Financial Services Guide | Privacy Policy
This website is owned and operated by Investogain Pty Limited.
ABN 88 129 443 447 | AFSL 334036
Information provided is of a general nature and not for trading or advice.
Copyright © 2002-2024 Investogain Pty Limited. All rights reserved.
